Ahmad, M.; Khan, S.; Shah, S.M.H.; Zahoor, M.; Hussain, Z.; Hussain, H.; Shah, S.W.A.; Ullah, R.; Alotaibi, A.
Correction: Ahmad et al. Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes. Biomedicines 2023, 11, 1064. Biomedicines 2025, 13, 2795.
https://doi.org/10.3390/biomedicines13112795
AMA Style
Ahmad M, Khan S, Shah SMH, Zahoor M, Hussain Z, Hussain H, Shah SWA, Ullah R, Alotaibi A.
Correction: Ahmad et al. Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes. Biomedicines 2023, 11, 1064. Biomedicines. 2025; 13(11):2795.
https://doi.org/10.3390/biomedicines13112795
Chicago/Turabian Style
Ahmad, Mubashir, Shahzeb Khan, Syed Muhammad Hassan Shah, Muhammad Zahoor, Zahid Hussain, Haya Hussain, Syed Wadood Ali Shah, Riaz Ullah, and Amal Alotaibi.
2025. "Correction: Ahmad et al. Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes. Biomedicines 2023, 11, 1064" Biomedicines 13, no. 11: 2795.
https://doi.org/10.3390/biomedicines13112795
APA Style
Ahmad, M., Khan, S., Shah, S. M. H., Zahoor, M., Hussain, Z., Hussain, H., Shah, S. W. A., Ullah, R., & Alotaibi, A.
(2025). Correction: Ahmad et al. Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes. Biomedicines 2023, 11, 1064. Biomedicines, 13(11), 2795.
https://doi.org/10.3390/biomedicines13112795
